PWMS News Search Results

Back to NewsWire Home
Back to
  Back to PeopleWithMS NewsWire 

March 2008 Off the Wire . . .




Pixantrone To Be Studied In Phase I/II Trial For Aggressive MS

Submitted by art on Thu, 2008-03-27 06:59.

Biopharmaceutical Company Cell Therapeutics, Inc. announced that its new drug pixantrone would be studied in a multicenter phase I/II trial for treating multiple sclerosis.

This is a (hopefully) improved version of Mitoxantrone, a drug already used in MS.

E-Mail the NewsWire e-mail the NewsWire ! ! ! - Handpainted and Customized Canes
 with any news items you discover 

copyright 2003